Ning Wang1, Ping Lu, Bing Ling, Ziyan Zhu, Lennart Hammarström. 1. Division of Clinical Immunology (F79), Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, SE14186, Stockholm, Sweden.
Abstract
PURPOSE: Selective immunoglobulin A deficiency (IgAD) is the most common primary immunodeficiency in Caucasians with a prevalence of 1:600. However, the prevalence of IgAD is markedly lower in East Asian countries but no genetic studies have been performed on IgAD individuals in the Mongoloid population. METHODS: We investigated the prevalence of IgAD in a large number of Chinese blood donors (n = 39,015) in Shanghai, China. We measured immunoglobulin class, IgG subclass and anti-IgA serum levels among the IgAD donors. These donors were subsequently tissue typed and the allele frequency was compared with the Shanghai bone marrow donor HLA registry. RESULTS: Seventeen IgAD Chinese blood donors were identified, giving a prevalence of 1: 2,295. Two previously identified IgAD blood donor samples were added in the subsequent tests. Most IgAD donors had serum IgG levels above the normal range with no major IgG subclass deficiency and one donor was weakly positive for anti-IgA. Two-thirds of the Chinese IgAD donors carried Caucasian IgAD associated risk haplotypes, including DRB1*0301-DQB1*0201, DRB1*0701-DQB1*0202 and DRB1*0102-DQB1*0501, giving a significantly higher frequency of these haplotypes as compared to the Shanghai bone marrow donor HLA registry. CONCLUSIONS: The prevalence of IgAD in Chinese in this study is markedly lower than in Caucasians. This is the first study to investigate the genetics of IgAD in the Mongoloid population and two-thirds of the Chinese IgAD donors showed a mixture of Caucasian IgAD risk haplotypes. The low prevalence of IgAD could potentially be due to the low frequency of the disease associated risk haplotypes in China.
PURPOSE: Selective immunoglobulin A deficiency (IgAD) is the most common primary immunodeficiency in Caucasians with a prevalence of 1:600. However, the prevalence of IgAD is markedly lower in East Asian countries but no genetic studies have been performed on IgAD individuals in the Mongoloid population. METHODS: We investigated the prevalence of IgAD in a large number of Chinese blood donors (n = 39,015) in Shanghai, China. We measured immunoglobulin class, IgG subclass and anti-IgA serum levels among the IgAD donors. These donors were subsequently tissue typed and the allele frequency was compared with the Shanghai bone marrow donor HLA registry. RESULTS: Seventeen IgAD Chinese blood donors were identified, giving a prevalence of 1: 2,295. Two previously identified IgAD blood donor samples were added in the subsequent tests. Most IgAD donors had serum IgG levels above the normal range with no major IgG subclass deficiency and one donor was weakly positive for anti-IgA. Two-thirds of the Chinese IgAD donors carried Caucasian IgAD associated risk haplotypes, including DRB1*0301-DQB1*0201, DRB1*0701-DQB1*0202 and DRB1*0102-DQB1*0501, giving a significantly higher frequency of these haplotypes as compared to the Shanghai bone marrow donor HLA registry. CONCLUSIONS: The prevalence of IgAD in Chinese in this study is markedly lower than in Caucasians. This is the first study to investigate the genetics of IgAD in the Mongoloid population and two-thirds of the Chinese IgAD donors showed a mixture of Caucasian IgAD risk haplotypes. The low prevalence of IgAD could potentially be due to the low frequency of the disease associated risk haplotypes in China.
Authors: Javad Mohammadi; Ryan Ramanujam; Sara Jarefors; Nima Rezaei; Asghar Aghamohammadi; Peter K Gregersen; Lennart Hammarström Journal: J Clin Immunol Date: 2009-10-16 Impact factor: 8.317
Authors: L M Noh; B A Nasuruddin; A H Abdul Latiff; R M Noah; M R Kamarul Azahar; M Z Norzila; I Zulkifli; H K Gill; N I Nik Zainal; A W M Suhaimi; N Y Nik Khairulddin; H Maraina; H I Intan; I Mat; M Shahnaz; Azizi B H O Journal: Med J Malaysia Date: 2013
Authors: Alexander Viktorin; Marcel Frankowiack; Leonid Padyukov; Zheng Chang; Erik Melén; Annika Sääf; Inger Kull; Lars Klareskog; Lennart Hammarström; Patrik K E Magnusson Journal: Hum Mol Genet Date: 2014-03-27 Impact factor: 6.150
Authors: Vaidotas Urbonas; Jolita Sadauskaite; Rimante Cerkauskiene; Arvydas Kaminskas; Markku Mäki; Kalle Kurppa Journal: Med Sci Monit Date: 2016-12-06